Global Alzheimer's Drugs Market 2012-2016


◆タイトル:Global Alzheimer's Drugs Market 2012-2016
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



TechNavio’s analysts forecast the Global Alzheimer’s Drugs market to grow at a CAGR of 3.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer’s Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market.

TechNavio’s report, the Global Alzheimer’s Drugs market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Alzheimer’s Drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space include Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.


1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
4.1. Market Research Process
4.2. Research Design
4.3. Research Methodology
5. Scope of the Report
5.1. Market Overview
5.2. Product Offerings
5.3. Product Profiles
6. Market Landscape
6.1. Global Alzheimer’s Drugs market 2012-2016
6.1.1. Market Size and Forecast
6.1.2. Market Size and Forecast For EU
7. Five Force Analysis
8. Geographical Segmentation
9. Rate of Incidence and Prevalence
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1. Forest Laboratories Inc.
17.1.1. Business Overview
17.1.2. Key Information
17.1.3. SWOT Analysis
17.2. Eisai Co., Ltd.
17.2.1. Business Overview
17.2.2. Key Information
17.2.3. SWOT Analysis
17.3. Novartis AG
17.3.1. Business Overview
17.3.2. Key Information
17.3.3. SWOT Analysis
17.4. H. Lundbeck A/S
17.4.1. Business Overview
17.4.2. Key Information
17.4.3. SWOT Analysis
17.5. Pfizer Inc.
17.5.1. Business Overview
17.5.2. Key Information
17.5.3. SWOT Analysis

18. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Alzheimer’s Drugs Market 2012-2016 (US$ billion)
Exhibit 3: Alzheimer’s Drugs Market in the EU 2012-2016 (US$ billion)
Exhibit 4: Global Alzheimer’s Drugs Market by Geographical Segmentation 2012


Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.



★調査レポート[世界のアルツハイマー治療薬市場(2012-2016)] (Global Alzheimer's Drugs Market 2012-2016 / IRTNTR2333)販売に関する免責事項
[世界のアルツハイマー治療薬市場(2012-2016)] (Global Alzheimer's Drugs Market 2012-2016 / IRTNTR2333)についてEメールでお問い合わせ